These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 22997972

  • 1. Influence of four different PTH methods on the classification of chronic kidney disease patients according to the new KDIGO guideline.
    Ten BE, Van Veen MC, Vervloet MG, Fischer JC, Koopman MG, Van Dam B.
    Clin Lab; 2012; 58(7-8):719-24. PubMed ID: 22997972
    [Abstract] [Full Text] [Related]

  • 2. Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values.
    Cavalier E, Delanaye P, Vranken L, Bekaert AC, Carlisi A, Chapelle JP, Souberbielle JC.
    Nephrol Dial Transplant; 2012 May; 27(5):1950-6. PubMed ID: 21940481
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the Elecsys PTH(1-84) assay with four contemporary second generation intact PTH assays and association with other biomarkers in chronic kidney disease patients.
    Tan K, Ong L, Sethi SK, Saw S.
    Clin Biochem; 2013 Jun; 46(9):781-6. PubMed ID: 23384535
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of IDS-iSYS intact parathyroid hormone (iPTH) and comparison to Siemens Advia Centaur iPTH assay in chronic renal failure patients and in controls.
    Koivula MK, Laitinen P, Risteli J.
    Clin Lab; 2012 Jun; 58(5-6):403-10. PubMed ID: 22783568
    [Abstract] [Full Text] [Related]

  • 5. Switching between parathormone (PTH) assays: the impact on the diagnosis of renal osteodystrophy.
    Bekő G, Butz H, Berta K, Tislér A, Olajos F, Vásárhelyi B, Patócs A.
    Clin Chem Lab Med; 2013 Jun; 51(6):1251-6. PubMed ID: 23241601
    [Abstract] [Full Text] [Related]

  • 6. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
    Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI.
    Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050
    [Abstract] [Full Text] [Related]

  • 7. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
    Isakova T, Nickolas TL, Denburg M, Yarlagadda S, Weiner DE, Gutiérrez OM, Bansal V, Rosas SE, Nigwekar S, Yee J, Kramer H.
    Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764
    [Abstract] [Full Text] [Related]

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 9. KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.
    Sarnak MJ, Bloom R, Muntner P, Rahman M, Saland JM, Wilson PW, Fried L.
    Am J Kidney Dis; 2015 Mar; 65(3):354-66. PubMed ID: 25465166
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease.
    Panawong W, Chaiyakum A, Pongskul C.
    J Med Assoc Thai; 2011 Oct; 94(10):1175-83. PubMed ID: 22145501
    [Abstract] [Full Text] [Related]

  • 15. Establishment of reference values in a healthy population and interpretation of serum PTH concentrations in hemodialyzed patients according to the KDIGO Guidelines using the Lumipulse® G whole PTH (3rd generation) assay.
    Cavalier E, Salsé M, Dupuy AM, Bargnoux AS, Watar F, Souberbielle JC, Delanaye P, Cristol JP.
    Clin Biochem; 2018 Apr; 54():119-122. PubMed ID: 29501417
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of a chemiluminescence immunoassay for the determination of intact parathyroid hormone using the ADVIA Centaur.
    Amal L, Bergmann P.
    Clin Lab; 2004 Apr; 50(11-12):695-702. PubMed ID: 15575312
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Variability in parathyroid hormone assays confounds clinical practice in chronic kidney disease patients.
    Eddington H, Hudson JE, Oliver RL, Fraser WD, Hutchison AJ, Kalra PA.
    Ann Clin Biochem; 2014 Mar; 51(Pt 2):228-36. PubMed ID: 24000371
    [Abstract] [Full Text] [Related]

  • 20. Higher parathyroid hormone (PTH) concentrations with the Architect PTH assay than with the Elecsys assay in hemodialysis patients, and a simple way to standardize these two methods.
    Monge M, Jean G, Bacri JL, Lemaitre V, Masy E, Joly D, Souberbielle JC.
    Clin Chem Lab Med; 2009 Mar; 47(3):362-6. PubMed ID: 19199835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.